ChiCTR2100050197尚未招募1 期
A pilot randomized controlled trial of integrative Motivational Interviewing and Contingency Management program (MICM) for dual-diagnosed patients to enhance psychiatric medication adherence
SELF1 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2021年8月23日最近更新:
干预措施
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 86
- 试验地点
- 1
- 主要终点
- MEDICATION ADHERENCE
研究概览
简要总结
The proposed project will adopt a single-blinded, multi-centre pilot randomized controlled trial (RCT) design to determine the feasibility and preliminary effectiveness of a multi-model, integrative Motivational Interviewing and Contingency Management program (MICM), in comparison with the usual care (i.e., case management), at immediately after intervention and 3-months post-intervention. The following outcomes will be assessed:
- medication adherence (primary outcome); and
- psychiatric symptoms, frequency of substance abuse and psychiatric hospitalizations (secondary outcomes). Moreover, the perceived usefulness and areas of improvement of the MICM program will be evaluated to make necessary improvement in the future clinical application.
研究设计
- 研究类型
- Interventional
- 主要目的
- 随机抽样
- 盲法
- None
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- All
入选标准
- •Adults, aged 18-64 years Hong Kong residents;
- •Diagnosed with substance-use disorder and comorbid with at least one type of other mental disorder in the Diagnostic and Statistical Manual – fourth version (text revised) (DSM-IV-TR) / fifth version (DSM-5), or International Classification of Diseases – 10th (ICD-10) / 11th version (ICD-11);
- •Able to give written consent as recommended by psychiatrist and read/write Chinese language;
- •Being prescribed at least one type of oral psychiatric medication.
排除标准
- •Having organic psychiatric disorder AND/OR learning disability;
- •Having been prescribed depot-only (injection) medication or no medication;
- •Having visual, language or communication difficulties.
研究组 & 干预措施
INTERVENTION
MOTIVATIONAL INTERVIEWING AND CONTINGENCY MANAGEMENT
Control group
NO TREATMENT
干预措施: NO TREATMENT
结局指标
主要结局
MEDICATION ADHERENCE
时间窗: PRE, IMMEDIATE POST, 3-MONTH POST
次要结局
- PSYCHIATRIC SYMPTOMS(PRE, IMMEDIATE POST, 3-MONTH POST)
- SUBSTANCE ABUSE(PRE, IMMEDIATE POST, 3-MONTH POST)
- PSYCHIATRIC HOSPITALIZATION(PRE, IMMEDIATE POST, 3-MONTH POST)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
2 期
Clinical study on sleep tablets in sleep problemInsomniaCTRI/2024/03/063637SciTech Specialties Pvt. Ltd.36
尚未招募
3 期
Therapist-aided App for Exposure and Response Prevention in patients with Obsessive-Compulsive DisorderCTRI/2024/08/072909IHUB Anubhuti-IITD Foundation (IHUB)20
尚未招募
4 期
A study to investigate safety and efficacy of iGlarLixi in adult patients with Type 2 diabetes mellitus.CTRI/2024/10/075222Sanofi Healthcare India Private limited,105
尚未招募
2 期
A clinical trial that will assess that effectivness of Rasanjanadi Lepa in treating Nadi Vrana (Pilonidal Sinus) through a randomised controlled trial.CTRI/2025/03/082732Dr Sarvagya Pathak172
招募中
3 期
A comparative study of Romiplostim Biosimilar with Nplate in Immune Thrombocytopenia patients.CTRI/2025/08/092989Levim Lifetech Private Limited72